News EU pharma calls for speedy shift to digital package inserts Pharma groups have called for EU adoption of electronic product information (ePI) to take place within four years in a new position paper.
News Pharma looking for progress as Brexit talks restart Pharma hoping for mutual recognition arrangement
Views & Analysis 3 Questions on biosimilars in Europe: Adrian van den Hoven Adrian van den Hoven of Medicines for Europe addresses three big questions facing the biosmilars sector in Europe in 2018.
News UK MHRA green lights AbbVie’s ELAHERE for ovarian cancer AbbVie has secured UK marketing authorisation for ELAHERE (mirvetuximab soravtansine), the first antibo
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face